MEET Michael Singer - EXECUTIVE CHAIRMAN

With 30 years of executive leadership, Michael Singer has significant operating, financial, investment, business/government and healthcare experience. In his career he has held positions as a Founding CEO of a medical technology company; the President of a substantial investment group; a CFO who took a private company public and then sold it; a Board member to several companies and organizations; an active private investor; and an investment banker specializing in Mergers & Acquisitions.

As Founding CEO of medical technology company BrainScope, Michael guided the company from technology development, clinical studies, product validation, Intellectual Property creation (100 patents), organizational build, and multiple (8) regulatory clearances to commercial launch of the first FDA-cleared medical device for assessment of the full spectrum of brain injury, including concussion. Working closely with the U.S. Food and Drug Administration (FDA) and the Department of Defense and using advanced AI techniques derived from multiple multi-site clinical studies, Michael led the company to such pathbreaking regulatory clearances as the “Concussion Index”, the “Brain Function Index”, and the “Structural Injury Classifier”. The benefit of this public-private partnership was detailed in the peer-reviewed Journal of Clinical and Translational Science. Michael also secured significant equity investment and research funding through government and military contracts.

Before Michael joined BrainScope, he was President of Revolution Health Investments, where he managed its sale to Everyday Health. He was previously the Chief Financial Officer, Executive Vice President of Corporate Development for Data Critical Corporation, a Seattle-based venture-backed medical device company. At Data Critical he was responsible for facilitating the company’s IPO and eventually led the sale of Data Critical to General Electric. He has also worked as an executive at Microsoft Corporation responsible for developing small business and healthcare strategies.  For a decade Michael was a healthcare investment banker and M&A generalist for Wolfensohn & Co., Alex. Brown and Montgomery Securities in New York and San Francisco. He started his career at Union Bank of Switzerland in Zurich.

Michael has served on the Board of Directors of Exact Sciences Corporation (molecular diagnostics), MedEfficiency (medical devices, sold to Derma Sciences), SparkPeople (consumer health), One Reel (entertainment), Data Critical Corporation (medical devices, sold to GE), BrainScope (medical devices), and EpiWatch (digital health).

Michael holds a Ph.D. from the London School of Economics.